INDP
Price:
$3.58
Market Cap:
$6.27M
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral infections. The firm's lead investigational compound, Decoy20, is currently progressing through Phase I clinical trials. This candidate is being evaluated for its capacity to elicit lasting therapeutic responses, either as a standalone agent or in combination with other treatments, for various conditions including lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as infections caused by the hepatitis B virus and human immunodeficiency virus. Initially incorporated in 2021 under t...[Read more]
Industry
Biotechnology
IPO Date
2015-08-04
Stock Exchange
NASDAQ
Ticker
INDP
According to Indaptus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.77M. This represents a change of -73.50% compared to the average of 18.00M of the last 4 quarters.
The mean historical Enterprise Value of Indaptus Therapeutics, Inc. over the last ten years is 1.50B. The current 4.77M Enterprise Value has changed -68.09% with respect to the historical average. Over the past ten years (40 quarters), INDP's Enterprise Value was at its highest in in the December 2018 quarter at 6.98B. The Enterprise Value was at its lowest in in the December 2025 quarter at -2200715.16.
Average
1.50B
Median
539.41M
Minimum
-5696207.16
Maximum
6.55B
Discovering the peaks and valleys of Indaptus Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 348.95%
Maximum Annual Enterprise Value = 6.55B
Minimum Annual Increase = -102.65%
Minimum Annual Enterprise Value = -5696207.16
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -5696207.16 | -102.65% |
| 2024 | 214.91M | -46.38% |
| 2023 | 400.81M | 22.99% |
| 2022 | 325.90M | -46.91% |
| 2021 | 613.90M | -70.59% |
| 2020 | 2.09B | 348.95% |
| 2019 | 464.92M | -92.90% |
| 2018 | 6.55B | 162.56% |
| 2017 | 2.49B | 37.69% |
| 2016 | 1.81B | 58.07% |
The current Enterprise Value of Indaptus Therapeutics, Inc. (INDP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
203.34M
5-year avg
309.96M
10-year avg
1.50B
Indaptus Therapeutics, Inc.’s Enterprise Value is greater than Silexion Therapeutics Ltd. (-665546.00), greater than Revelation Biosciences, Inc. (-9460412.00), greater than Psyence Biomedical Ltd. (-6071833.00), less than NKGen Biotech, Inc. Common Stock (46.02M), greater than GT Biopharma, Inc. (-4175034.00), greater than Avenue Therapeutics, Inc. (-1362611.00), greater than Protagenic Therapeutics, Inc. (1.85M), greater than Salarius Pharmaceuticals, Inc. (-4623480.00), greater than Lipella Pharmaceuticals Inc. (-1222021.00), greater than Azitra, Inc. (-7333404.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -665546.00 | $1.31M | |
| -9460412.00 | $3.89M | |
| -6071833.00 | $63.33K | |
| 46.02M | $7.84M | |
| -4175034.00 | $4.75M | |
| -1362611.00 | $1.05M | |
| 1.85M | $905.10K | |
| -4623480.00 | $4.92M | |
| -1222021.00 | $369.67K | |
| -7333404.00 | $2.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Indaptus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Indaptus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Indaptus Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Indaptus Therapeutics, Inc. (INDP)?
What is the 3-year average Enterprise Value for Indaptus Therapeutics, Inc. (INDP)?
What is the 5-year average Enterprise Value for Indaptus Therapeutics, Inc. (INDP)?
How does the current Enterprise Value for Indaptus Therapeutics, Inc. (INDP) compare to its historical average?